These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5009592)

  • 41. Purine metabolism in high- and low-uric acid lines of chickens: hypoxanthine/guanine phosphoribosyltransferase activities.
    McFarland DC; Coon CN
    Proc Soc Exp Biol Med; 1983 May; 173(1):41-7. PubMed ID: 6407025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human hypoxanthine-guanine phosphoribosyltransferase. Detection of a mutant allele by restriction endonuclease analysis.
    Wilson JM; Frossard P; Nussbaum RL; Caskey CT; Kelley WN
    J Clin Invest; 1983 Sep; 72(3):767-72. PubMed ID: 6309910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Bunn DN; Moss IK; Nicholls A; Scott JT; Snaith ML; Watson MR
    Ann Rheum Dis; 1975 Jun; 34(3):249-55. PubMed ID: 1155984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recessive X-linked hyperuricemia with gout and renal damage, normal activity of hypoxanthine phosphoribosyltransferase and resistance to azaguanine.
    Westberg NG; Rosén E; Waldenström J
    Acta Med Scand; 1979; 205(3):163-7. PubMed ID: 425844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inheritance of hypoxanthine-guanine phosphoribosyltransferase deficiency and detection of heterozygotes.
    Henderson JF
    Fed Proc; 1968; 27(4):1085-6. PubMed ID: 5658475
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Sorensen LB
    J Clin Invest; 1970 May; 49(5):968-78. PubMed ID: 5441549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activities of hypoxanthine-guanine phosphoribosyltransferase and adenine phosphoribosyltransferase in erythrocytes from patients with Down's syndrome.
    Tada K; Uesaki T; Isshiki G; Oura T
    Tohoku J Exp Med; 1972 Oct; 108(2):197-8. PubMed ID: 4265623
    [No Abstract]   [Full Text] [Related]  

  • 48. Properties of erythrocyte purine phosphoribosyltransferases in partial hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Sperling O; Boer P; De Vries A
    Adv Exp Med Biol; 1973; 41():211-3. PubMed ID: 4791193
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of xanthine oxidase in hyperuricemic states.
    Marcolongo R; Marinello E; Pompucci G; Pagani R
    Arthritis Rheum; 1974; 17(4):430-8. PubMed ID: 4855072
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical features of patients with the "partial" deficiency of the X-linked uricaciduria enzyme.
    Greene ML
    Arch Intern Med; 1972 Aug; 130(2):193-8. PubMed ID: 5050554
    [No Abstract]   [Full Text] [Related]  

  • 51. Adenine phosphoribosyltransferase deficiency: report of a second family.
    Fox IH; Kelley WN
    Adv Exp Med Biol; 1973; 41():319-26. PubMed ID: 4791204
    [No Abstract]   [Full Text] [Related]  

  • 52. [From Lesch-Nyhan disease to primary gout].
    Ryckewaert A; Audeval B; Kuntz D
    Rev Eur Etud Clin Biol; 1970; 15(6):605-9. PubMed ID: 4919604
    [No Abstract]   [Full Text] [Related]  

  • 53. Survey of serum uric acid concentration in an institutionalized mentally retarded population.
    Bland JH; Jarrett FA; Plunkett GE; Ravaris CL; Sylwester D
    Fed Proc; 1968; 27(4):1087-90. PubMed ID: 5658476
    [No Abstract]   [Full Text] [Related]  

  • 54. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract]   [Full Text] [Related]  

  • 55. Gout with adenine phosphoribosyl transferase deficiency.
    Delbarre F; Auscher C; Amor B; de Gery A
    Adv Exp Med Biol; 1973; 41():333-9. PubMed ID: 4791206
    [No Abstract]   [Full Text] [Related]  

  • 56. A new disorder of purine metabolism with behavioral manifestations.
    Nyhan WL; James JA; Teberg AJ; Sweetman L; Nelson LG
    J Pediatr; 1969 Jan; 74(1):20-7. PubMed ID: 5782823
    [No Abstract]   [Full Text] [Related]  

  • 57. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.
    Benke PJ; Herrick N
    Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

  • 59. An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Kelley WN; Rosenbloom FM; Miller J; Seegmiller JE
    N Engl J Med; 1968 Feb; 278(6):287-93. PubMed ID: 5638346
    [No Abstract]   [Full Text] [Related]  

  • 60. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients.
    Hershfield MS
    J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.